SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001651308-22-000018
Filing Date
2022-02-08
Accepted
2022-02-08 18:19:54
Documents
3
Period of Report
2022-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_164436237916672.html 3  
1 FORM 3 wf-form3_164436237916672.xml 3 1752
2 MD - POA HTML duganex241.htm EX-24 4848
3 MD - POA GRAPHIC duganex241001.jpg GRAPHIC 291158
  Complete submission text file 0001651308-22-000018.txt   409208
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVE, CAMANA BAY, PO BOX 1348 GRAND CAYMAN E9 KY1-1108
Business Address
Dugan Margaret (Reporting) CIK: 0001909734 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37686 | Film No.: 22603181